作者
Steven M. Horwitz,Stephen M. Ansell,Weiyun Z. Ai,Jeffrey A. Barnes,Stefan K. Barta,Jonathan E. Brammer,Mark W. Clemens,Ahmet Doğan,Francine M. Foss,Paola Ghione,Aaron M. Goodman,Joan Guitart,Ahmad Halwani,Bradley M. Haverkos,Richard T. Hoppe,Eric Jacobsen,Deepa Jagadeesh,Allison Jones,Avyakta Kallam,Youn H. Kim,K.A. Kumar,Neha Mehta‐Shah,Elise A. Olsen,Saurabh Rajguru,Sima Rozati,Jonathan W. Said,Aaron C. Shaver,Lauren Shea,Michi M. Shinohara,Lubomir Sokol,Carlos A. Torres‐Cabala,Ryan A. Wilcox,Peggy A. Wu,Jasmine Zain,Mary A. Dwyer,Hema Sundar
摘要
Peripheral T-cell lymphomas (PTCLs) are a heterogeneous group of lymphoproliferative disorders arising from mature T cells, accounting for about 10% of non-Hodgkin lymphomas. PTCL-not otherwise specified is the most common subtype, followed by angioimmunoblastic T-cell lymphoma, anaplastic large cell lymphoma, anaplastic lymphoma kinase–positive, anaplastic large cell lymphoma, anaplastic lymphoma kinase–negative, and enteropathy-associated T-cell lymphoma. This discussion section focuses on the diagnosis and treatment of PTCLs as outlined in the NCCN Guidelines for T-Cell Lymphomas.